Mechanistically, Lkb1 behaves as a molecular rheostat for Kras, and in the context of Lkb1 deficiency, Kras aberrant activation has been found to induce the formation of both lung adenosquamous cell carcinoma and SCC [115]. The gene discussed is KRAS; the disease is adenosquamous lung carcinoma.